Skip to main content

Closing Bell: Cipher Pharmaceuticals Inc down on Tuesday (CPH)

Automated Summaries - The Globe and Mail - Tue Jul 16, 4:01PM CDT

In market activity today, Cipher Pharmaceuticals Inc opened at $8.58 and closed at $8.31. prices ranged from $8.31 to $8.58.

The price dipped -0.60% from the previous day's close of $8.36.

Today across North America, the TSX Composite closed 0.34% at 22751.68, the S&P 500 closed 0.28% at 5631.22, the Dow Jones Industrial Average closed 0.53% at 40211.72 and the Nasdaq Composite closed 0.40% at 18472.57.

Cipher Pharmaceuticals Inc traded under CPH on the Toronto Stock Exchange (TSX).

Trading volume was 10,051 on 69 total trades. On average, Cipher Pharmaceuticals Inc has traded 16,163 shares over 5 days and 32,342 year-to-date.

The TSX overall saw 4,226 price advancers against 1,023 declines and 82 unchanged.

During the prior 52 weeks, CPH.TO has traded as high as $10.33 (May 10,2024) and low as $3.35 (August 08,2023). Moreover, in the last 12 months, Cipher Pharmaceuticals Inc's shares have risen 136.08 percent, while they have soared 50.00% since the start of 2024.

Following today's trading, Cipher Pharmaceuticals Inc has a market capitalization of $201.58 million on a float of 24,113 shares outstanding. Its annual EPS is $0.90.

Cipher Pharmaceuticals Inc is a TSX Drug Specialty & Generic company headquartered in Mississauga, CAN.

Currently, Cipher Pharmaceuticals Inc's consensus rating is "Moderate Buy" based on 2 analysts according to Zacks. Currently, there are 1 buy ratings and 1 hold ratings for the stock.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..